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Abstract
The clinical fails of gold (Au) and carbon (C) coated 316LSS stents have been barely investigated. A comprehensive understanding of these fails may contribute to 
the improvement of protocols for the development of better materials and surfaces. This work elucidates the reasons of the clinical fails of Au and C coated 316LSS 
stents, demonstrates the physical-chemical processes that leaded to these fails, reviews the mistaken line of thought that pushed these technologies to the most 
advanced clinical stages and proposes complementary techniques to the FDA guidances for the early non-clinical engineering tests. Au and C coated 316LSS, bare-
metal 316LSS and Co-Cr stents were studied using potentiodynamic scans according to FDA guidance protocols, image analysis and bulk elemental composition. 
The statistical clinical outcome of the stents was found to correlate with the ions release patterns eluted from their corresponding metallic substrates. In all cases ions 
release were consequence of post-passive corrosion processes such as pitting corrosion of 316LSS and bulk grain dissolution of Co-Cr alloy. Surprisingly, the stents 
outcome did not correlate with their corresponding corrosion rates. Clinical fails of Au and C coated 316LSS stents are explained in terms of their fails to inhibit 
the ions release from their 316LSS substrates. Materials and surface improvements must be oriented to inhibit post-passive corrosion processes of stents substrates. 
Potentiodynamic scans complemented with image analysis are strongly recommended for the evaluation of pre-clinical engineering tests.
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Introduction
Each year, nearly 1.4 million stents are implanted worldwide [1]. 
The majority of implanted stents are made of AISI 316L stainless steel 
(316LSS) and cobalt-chromium (Co-Cr) alloy [2]. Their excellent 
mechanical properties and corrosion resistance are the reasons 
for their prevalence [3,4]. However, they present some limitations 
including restenosis and thrombosis [5,6]. The corrosion of these alloys 
plays an important role on the implants outcome [3,7,8]. Corrosion 
processes release toxic ions to the surrounding tissues changing the 
chemistry at the implant zone, promoting an overgrowth of endothelial 
cells, activating the immune cells and ultimately giving rise to an 
inflammatory response and restenosis [9]. Contact allergy to metal 
ions has been suggested to contribute to restenosis throw inflammation 
and release of chemotactic and growth factors [10]. Corrosion also 
affects the integrity of the implant. Stent fracture due to corrosion has 
been detected in 1-3% of coronary cases [11] and has been associated 
to platelet activation, stent thrombosis and neointimal growth with 
upregulation of proinflammatory factors [12].
Metal ions toxicity has been reviewed in a solid bibliographic work 
[13]. This report concludes that ions toxicity depends on the chemical 
composition of the alloy, the surface condition, the size and dimensions 
of the implant, the releasing time, the oxidation state of released ions 
and the synergistic effects between the ions. Moreover, the toxicity rank 
for the main ions released from 316LSS and Co-Cr alloys was reported 
as: Cr+6>Ni+2>Cr+3>Co+3>Fe+3.
A variety of materials have been used as coating for cardiovascular 
metallic stents [14]. These materials are intended to improve the 
biocompatibility of the stents by preventing ions release from their 
surface. 
The majority of these coatings did not pass the research stages, a 
few were moved to clinical trials and very few were finally approved by 
regulatory agencies and allowed to be industrially manufactured and 
globally marketed. Gold (Au) and carbon (C) coated 316LSS stents are 
cases of study. They passed all research stages, they were approved by 
the World's most exigent regulatory agencies and they were industrially 
manufactured and globally marketed. However, after an enthusiastic 
initial period, Au and C coated stents were abandoned due to their poor 
clinical results.
The reasons for the clinical fails of Au and C coated stents were 
barely investigated and quickly condemned to oblivion even after 
been responsible for enormous expenses in research, trials, intellectual 
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property development, market launches and ultimately disability-
adjusted life years associated to the implantation of Au and C coated 
stents when compared against bare-metal stents made of 316LSS and 
Co-Cr. 
Au has high corrosion resistance and high fluoroscopic visibility 
[15]. Au coated stents were widely used in coronary stenting procedures. 
Animal studies suggested that Au might reduce thrombosis due to its 
inertness, low platelet adhesion and low thrombus formation [16]. 
However, a significant increment of the restenosis rate associated to 
implanted Au coated stents was confirmed in comparative clinical trials 
against bare-metal stents [17-19]. Despite proving excellent corrosion 
behavior, Au coated stents resulted with high rates of restenosis [20]. 
Delamination of the Au coating, further exposition of the 316LSS 
substrate to the physiological medium and ultimate ion release due to 
corrosion of the implant were proposed to explain the poor outcome of 
Au coated stents [21]. Another studies revealed very high concentration 
of Au in the blood of patients implanted with Au coated stents when 
compared against patients implanted with Nitinol stents. Additionally, 
these studies established a correlation between the high levels of 
Au in blood with contact allergy reaction to this metal [10,22]. Au 
dissolution, Au ions diffusion and/or dispersion of Au coating debris 
were hypothesized to be the reasons to explain the contact allergy 
reactions and the high levels of Au in the body [23]. 
C is a inert material used for stent coating in the past. Pre-clinical 
trials of C coated Nitinol stent showed the absence of mural thrombi, 
low inflammatory response and early endothelialization [24]. C coated 
316LSS stents reduced the restenosis rate to 11% [25]. However, these 
results were not consistent with other studies. A comparative study 
between bare-metal 316LSS stents and C coated 316LSS stents showed 
that the C coating did not influence the inflammatory response of 
the implants [26,27]. Another study also documented comparable 
restenosis rate and major adverse events between bare-metal 316LSS 
stent and C coated 316LSS stents [28]. 
After their clinical fails Au and C coated stents were retired from 
the market. Furthermore, little and highly speculative analysis on 
the understanding of why Au and C coated stents failed in reducing 
restenosis rate has been done. The aim of this contribution is to elucidate 
the technical reasons of the clinical fails of Au and C coated stents. The 
paper also discuss and criticize the actual protocols for materials and 
processes development for stent coatings. Finally, we propose new, fast, 
easy and cheap in-vitro protocol to test the performance of coatings 
deposited over metallic stents before its derivation to clinical trials.
Materials and methods 
Coronary stents made of 316LSS and Co-Cr alloy (Aeromedical, 
Argentina), Au coated 316LSS stents (Inflow Gold Flex System, Inflow 
Dynamics) and C coated 316LSS stents (CarbonfilmTM Coated Coronary 
Stent. Sorin Biomedical) were used as case materials. Sodium chloride, 
potassium chloride, monosodium phosphate and potassium phosphate 
dibasic (Anedra, Argentina) were used to prepare phosphate-buffered 
saline solution (PBS).
An optical microscope (OM) Leica DM 2500 M (Leica 
Microsystems, Germany) powered with Leica Application Suite 
Version 2.8.1. software and a scanning electron microscope (SEM) 
(JEOL JSM-35C, USA) operating at 20 kV were used for measuring 
the area of the stents and for the observation of the structure, integrity 
and surface of the stents before and after the crimping process and 
before and after corrosion tests. The area of stents was calculated using 
a precision image analyzer software (ImageJ Wayne Rasband, USA).
Energy-dispersive X-ray spectroscopy (EDX) analysis was 
performed using an X-ray microprobe (JEOL, USA) coupled to the 
SEM and served to evaluate chemical composition of the bulk stent 
material. 
The corrosion susceptibility of the stents were evaluated 
according to the FDA guidance for non-clinical engineering tests 
and recommended labeling for intravascular stents [29]. This FDA 
guidance recommend the use of the ASTM F2129 standard to 
evaluate the corrosion resistance of the stent [30]. The test consists 
in a potentiodynamic scan of the stent. The electrochemical system 
consisted of a conventional three-electrode cell including a working 
electrode made of a stent, a saturated calomel electrode (SCE) as a 
reference electrode and a platinum plate as a counter electrode, 
connected to a potentiostat (Gamry Reference 600, USA). The stents 
were attached at one end to a copper wire using a conductive silver 
glue. The wire was inserted in a glass tube and the end of the tube was 
filled with metallographic epoxy resin to isolate the joint between the 
stent and the wire from the electrolyte. The electrolytic medium was 
PBS at pH=7.4 and T=37°C. 
First, the stents were leave under open circuit potential (OCP) 
condition during two hours to reach their Rest Potential (Er). The 
potentiodynamic polarization scan E (potential) vs I (current) was 
performed in the anodic direction from Er (-100 mVvs OCP) to 1.4 V 
at a scan rate of 0.5 mV/s. The critical breakdown potential (Eb) was 
obtained from the potentiodynamic polarization curves. The corrosion 
potential (Ecor) and corrosion current density (Icor) were obtained 
according to Tafel method [31]. Corrosion rate (CR) was calculated 
according to equation 1.
CR=Icor K EW / d    Eq. 1
Here, K is a constant depending on units (mm A-1cm-1year-1), EW 
is the equivalent weight (g) and d is the density of the corresponding 
material (g cm-3). The test were performed by triplicates on un-
expanded and expanded stents. 
Results 
Figure 1 presents SEM images of the stents. All stents present a 
smooth surface with no evident defects such burrs and inclusions 
coming from manufacturing processes. Au and C coated stents 
presented good coverage without any microscopic imperfection of the 
coating and no exposed substrate material. EDX analysis of all stents 
are shown in Table 1.
316LSS stents present an elemental composition according to the 
ASTM A 240/A 240M specification for 316LSS alloy. The 100% Au 
composition evidenced in Au coated 316LSS stents indicates that the 
thickness of the Au coat is higher than 1 micron. In this case, the high-
energy beam of electrons interacts with the upper Au volume part of 
the coat. The C coated 316LSS stents present a 316LSS basic elemental 
composition with partial substitution of Fe, Ni and Mo by Co and W 
additions. The C coating resulted transparent to EDX due to its low 
atomic weight. Finally, Co-Cr stents present a composition according 
to the L605 Co-Cr standard alloy.
Figure 2 presents the stent's OCP time evolution. All stents 
reached a stable value within the first hour of evaluation. The OCP 
of C coated stents exhibited the highest initial value followed by a 
concave-up decrease. C coated stents reached Er=-0.2VSCE at 60 
minutes. C coated stents presented the most positive potential 
meaning that C promotes a more passive behavior when compared 
Navarro L (2020) Coating induced corrosion of coronary stents - A comparative study with clinical consequences
 Volume 20: 3-6Trends Med, 2020                doi: 10.15761/TiM.1000220
a linear decrease reaching Er=-0.5VSCE at 30 minutes. The Au coated and 
316LSS stents registered similar Er values. 
Figure 3 presents the potentiodynamic scans. The corrosion 
parameters are depicted in Table 2. 316LSS stents resulted with the 
highest Icor, Ecor and CR. The shifting from the cathodic behavior to 
the dissolution zone occurred at E=-0.38VSCE. The material showed a 
passive behavior within -0.23VSCE<E<0.48VSCE. The breakdown of the 
passive zone started at E=0.48VSCE and I sharply increased at E>0.62VSCE. 
The scans corresponding to Au and C coated 316LSS stents and Co-
Cr stents are shifted to lower I values when compared to bare-metal 
316LSS stents. Au coated stents resulted with the lowest CR and Ecor, 
and high Eb. Au coated 316LSS stents presented a CR 2515 times lower 
than bare-metal 316LSS stents.
The shifting from the cathodic behavior to the active dissolution 
zone occurred at E=-0.62VSCE. The material showed a proportional 
increment of E with the increment of I within -0.62VSCE<E<0.60VSCE. 
I sharply increased at E>0.60VSCE. The material did not passivate. C 
coated stents presented potentiodynamic properties between Au coated 
stents and 316LSS stents. The shifting from the cathodic behavior to the 
dissolution zone occurred at E=-0.52VSCE. Two passive zones are clearly 
identified within -0.40VSCE<E<-0.25VSCE and 0.41VSCE<E<0.61VSCE, 
respectively. The second passive zone looks similar to the upper 
part of the passive zone of bare-metal 316LSS stents. Co-Cr stents 
presented potentiodynamic properties similar to Au coated stents 
Figure 1. SEM images of stents. A) Bare-metal 316LSS; B) Au coated 316LSS; C) C 
coated 316LSS; D) Co-Cr alloy
Figure 2. Rest potential of stents
Stent Cr% Fe% Ni% Mo% Mn% Au% Co% W%
Bare-metal 316LSS 19.95 60.98 12.48 4.03 2.33 - - --
Au coated 316LSS - - - - - 100 -
C coated 316LSS 20.48 53.80 11.76 3.08 2.31 - 6.73 1.84
Co-Cr alloy 23.23 2.26 9.04 - 1.70 - 50.21 13.55
Table 1. Elemental composition
Parameter Bare-metal 316LSS
Au coated 
316LSS
C coated 
316LSS Co-Cr alloy
Ecor (VSCE) -0.38±0.01 -0.62±0.05 -0.52±0.08 -0.62±0.02
Eb (VSCE) 0.62±0.08 0.60±0.01 0.61±0.07 0.33±0.04
Icor (A/cm2) 1.2E-6±3E-7 4.5E-9±6E-10 2.2E-7±9E-8 1.4E-9±8E-10
CR (mm/year) 1.7E-2±3E-3 6.6E-6±8E-10 3.1E-3±9E-4 1.3E-5±5E-6
Table 2. Corrosion parameters
Figure 3. Potentiodynamic scans of stents
against the other stent materials. The OCP of Co-Cr stents exhibited 
lower initial value than C coated stents and followed by a concave-up 
decrease. Co-Cr stents reached Er=-0.40VSCE at 30 minutes. The OCP 
of 316LSS stents exhibited a low initial value followed by a concave-
up decrease to the more negative potential zone. 316LSS stents reached 
Er=-0.5VSCE at 15 minutes. The OCP of Au coated stents exhibited a low 
initial value followed by a 2 minutes linear increment and subsequently 
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at low E. The shifting from the cathodic behavior to the dissolution 
zone occurred at E=-0.62VSCE. Four passive zones are identified within 
-0.50VSCE<E<-0.24VSCE, -0.24VSCE<E<-0.20VSCE, 0.05VSCE<E<0.11VSCE 
and 0.27VSCE<E<0.33VSCE, respectively. I sharply increased when 
E>0.33VSCE. Co-Cr stents presented the lowest Eb in comparison with 
the rest of the stents.
Figures 4 (a-d) show the surfaces of 316LSS, Au coated, C coated 
and Co-Cr alloy stents after the electrochemical analysis. 316LSS stents 
showed pits of all sizes and complete struts dissolution. Au coated stents 
showed coating delamination and exposition of the 316LSS substrate. C 
coated stents revealed coating delamination, exposition of the 316LSS 
substrate and small pits. Co-Cr stents showed evidence of intragranular 
corrosion with massive material dissolution.
Discussion
OM and SEM imaging, EDAX analysis and OCP evaluation 
resulted according to expected results and confirmed the quality of 
used materials and the reliability of the characterization techniques.
The stents can be CR ranked as: Au coated 316LSS<Co-Cr<C 
coated 316LSS<316LSS bare-metal. Therefore, according to the FDA 
guidances the stents can be corrosion resistance ranked as: 316LSS 
bare-metal<C coated 316LSS<Co-Cr<Au coated 316LSS. But, the 
clinical evidence revealed the following increasing ranking in restenosis 
rate: Cr-Co<316LSS bare-metal=C coated 316LSS<Au coated 316LSS. 
Herein lies the main issue of discussion. It is evident that a decrease 
of the stent CR cannot be directly correlated to a decrease of the stent 
restenosis rate.
The efforts in the attempt of decreasing the restenosis rate were 
misguidedly oriented in the direction of reducing the CR of the stents 
material. Taking the 316LSS bare-metal stent as reference material, 
the CR was successfully reduced 5, 1277 and 2515 times by coating 
the 316LSS substrate with C, by substituting the 316LSS with Co-
Cr alloy and by coating the 316LSS substrate with Au, respectively. 
Disappointedly, these promising results were not reflected in clinical 
efficiencies. Therefore, pre-clinical decisions based exclusively on CR 
values may lead to great clinical fails.
However, potentiodynamic scans complemented with image 
analysis give valuable information. The effect of C coating on 316LSS 
stent substrate decreased the CR and promoted the apparition of a C coat 
based first passive zone. When this coating was breached, the 316LSS 
substrate resulted exposed, I rapidly increased and the C coated 316LSS 
stent tended to match the electrochemical behavior of the 316LSS bare-
metal stent. The passivation of the exposed 316LSS stent substrate is 
identified as the second passive zone located in the upper part of the 
potentiodynamic scan. Moreover, the breakdown of the second passive 
zone of the C coated 316LSS stents and the passive zone of the 316LSS 
bare-metal stents occurred at similar Eb and I. Moreover, in both cases, 
the breakdown of the passive zones resulted in pitting corrosion of the 
316LSS material. The substitution of 316LSS bare-metal stent by Co-Cr 
bare-metal stent decreased the CR and promoted the apparition of four 
passive zones. These passive zones probably correspond to the formation 
of complex oxides based on Cr+2, Cr+3, Cr+4 and Cr+6. Interestingly, the 
last passive zone breakdown at the lowest Eb among the studied stents 
and at similar I than C coated 316LSS stent and 316LSS bare-metal 
stent. Image analysis suggests different chemical composition, and 
thus dissolution rate, between the bulk and the border of the Co-Cr 
metallic grains of the alloy. Such chemical segregation is common in Cr 
alloys and in most of the cases it is a consequence of heat treatments. 
In Co-Cr stents, chemical segregation can be the consequence of the 
heat treatment suffered by the alloy during the laser cut manufacturing 
process. Finally, the effect of Au coating on 316LSS stent decreased the 
CR. Apparently, the Au coating dissolves gradually with proportional 
increment of E and I. This gradual dissolution process explains the high 
levels of Au found in patients implanted with Au coated stents. When 
the Au coating eventually breached, the 316LSS substrate resulted 
exposed, and I sharply increased at Eb similar to the Eb observed for 
C coated 316LSS stents and 316LSS bare-metal stents. Moreover, the 
breakdown of the Au coating also resulted in pitting corrosion of the 
316LSS substrate.
It is evident that restenosis rate is more related to the toxicity 
of released metal ions than to the CR. The higher the toxicity of the 
released ions is, the higher the restenosis rate will be. Co-Cr stents have 
lower restenosis rate than 316LSS stents. Evidently, the grain dissolution 
of the Co-Cr alloy releases less toxic corrosion products than the pitting 
corrosion process of 316LSS. This result can be explained in terms of the 
total amount and oxidation states of the ions released from the 316LSS 
and Co-Cr alloys after the breakdown of their corresponding passives 
zones. In both cases, the breakdown of passives zones occurred at I=1 
E-4 A cm-2. This amount can be transformed to 1.036 E-9 e- mols cm-2s-1 
Figure 4. Stent surfaces after electrochemical test. A) Bare-metal 316LSS; B) Au coated 
316LSS; C) C coated 316LSS; D) Co-Cr alloy
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by using the definition of Coulomb and the Faraday constant. The total 
amount of electrons evolved from the system must be balanced with 
an equal amount of positive charges provided by the released ions. The 
oxidation states of the ions can be assumed according to the literature 
data presented in the introduction. Image analysis suggested that the 
ion release composition of 316LSS and Co-Cr alloys must be equal, or 
very similar, to their corresponding bulk alloy compositions.
Pitting corrosion of 316LSS generated pits through the bulk 
material and the dissolution of the Co-Cr progressed through the bulk 
grain of the alloy. Finally, the released ion composition and quantity 
for 316LSS and Co-Cr alloy in post-passive breakdown corrosion 
conditions at I=1 E-4 A cm-2 is summarized in Table 3. 
Clearly, stents made of Co-Cr alloy releases 21,14% more Cr ions 
and 24,64% less Ni ions than stents made of bare-metal 316LSS. The 
changes in the type and quantity of the other ions are not as significant 
as the changes in Cr and Ni ions. The great reduction of Ni ions released 
from the Co-Cr stents may justify its statistically lower restenosis rate 
when compared against bare-metal 316LSS stents. 
C coated 316LSS stents release 3,15% more Cr ions and 5,51% less 
Ni ions than bare-metal 316LSS stents. These small differences may 
justify their statistically similar restenosis rates. The changes in the 
type and quantity of the other ions do not have an evident effect on the 
restenosis rate.
Finally, the potentiondynamic scans confirmed the release of great 
amounts of Au from Au coated 316LSS stents. Additionally, the release 
of Cr and Ni ions can be assumed similar to those evidenced for bare-
metal 316LSS stents and C coated 316LSS stents. Here, the presence of 
Au ions, its associated allergy to arterial tissues and probably synergistic 
toxic effect with Cr and Ni ions may justify its statistically higher 
restenosis rate when compared against bare-metal 316LSS stents.
These findings suggest the use of image analysis as crucial 
complement to the ASTM F2129 standard. Image analysis permits the 
evaluation of initial surface conditions of the stents, early detection of 
surface coating defects and the morphology and extent of corrosion. 
The above exposed correlation between the amount of released ions to 
the statistical restenosis rate of different stents resulted from the image 
based confirmation of pitting corrosion and grain bulk dissolution of 
the 316LSS and Co-Cr alloy stent substrates. This confirmation allowed 
to assume the composition of released corrosion products to be equal 
to the alloy composition of the stent substrates.
Conclusions
The clinical fails of Au and C coated 316LSS stents were associated 
to the fails of the Au and C coats in impairing the pitting corrosion 
of the 316LSS stent substrate and thus its consequent release of toxic 
ions to physiologic media. The statistically similar outcome of C 
coated 316LSS stents and bare-metal 316LSS stents was associated to 
similar ion composition of corrosion products derived from similar 
development of pitting corrosion processes in their 316LSS substrates. 
The high restenosis rate of Au coated 316LSS stents was associated to 
the dissolution of the Au coating and a synergistic toxic effect of Au ions 
with the ion composition of corrosion products coming from pitting 
corrosion processes of the 316LSS substrate. And the low restenosis rate 
of Co-Cr stents was associated to a significant decrease of the amount of 
Ni ions released from the Co-Cr alloy when compared against 316LSS.
A decrease in the corrosion rate of 316LSS stents can not be directly 
associated to a decrease its restenosis rate. However, the technical 
evidence strongly suggest that a decrease or inhibition of Ni ion release 
from 316LSS stent substrates will reduce significantly its restenosis 
rate. Ni ion release can be reduced or inhibited by impairing the pitting 
corrosion process of 316LSS stent substrates or by changing the stent 
substrate by alloys with lower Ni content.
The application of the ASTM F2129 standard as FDA guidance 
for pre-clinical engineering tests with complementary image analysis 
is strongly recommended for the evaluation of stents pre-clinical 
engineering tests.
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